Your browser doesn't support javascript.
loading
Novel predictive scoring system for morbid hypothalamic obesity in patients with pediatric craniopharyngioma.
Fouda, Mohammed A; Zurakowski, David; Scott, R Michael; Marcus, Karen J; Manley, Peter E; Ullrich, Nicole J; Cohen, Laurie E; Goumnerova, Liliana C.
Afiliação
  • Fouda MA; Department of Neurosurgery, Boston Children's Hospital, Boston, MA, USA. Mfouda1@jhmi.edu.
  • Zurakowski D; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Mfouda1@jhmi.edu.
  • Scott RM; Division of Biostatistics, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, MA, USA.
  • Marcus KJ; Department of Neurosurgery, Boston Children's Hospital, Boston, MA, USA.
  • Manley PE; Division of Radiation Oncology, Boston Children's Hospital, Boston, MA, USA.
  • Ullrich NJ; Dana Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
  • Cohen LE; Division of Endocrinology, Boston Children's Hospital, Boston, MA, USA.
  • Goumnerova LC; Dana Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
Childs Nerv Syst ; 37(2): 403-410, 2021 02.
Article em En | MEDLINE | ID: mdl-32888069
ABSTRACT

PURPOSE:

To identify the independent risk factors for developing morbid hypothalamic obesity, to propose a predictive scoring system for morbid hypothalamic obesity, and to propose an algorithm for management in order to minimize the risk of developing morbid hypothalamic obesity in patients with pediatric craniopharyngioma.

METHODS:

A retrospective analysis of all pediatric craniopharyngioma patients diagnosed and treated at Boston Children's Hospital (BCH) between 1985 and 2017. Analysis of the data was conducted using IBM SPSS Statistics.

RESULTS:

We identified 105 patients, 90 (47 males and 43 females) fulfilled the inclusion criteria. The median age of patients at time of diagnosis was 8.4 years. The median follow-up was 10.6 years. Morbid hypothalamic obesity was evident in 28 (31.1%) patients at the last follow-up visit. Age of patients at time of diagnosis > 10 years (P = 0.023), preoperative body mass index (BMI) > 95th percentile (P = 0.006), and preoperative papilledema (P < 0.001) were the independent risk factors for developing morbid hypothalamic obesity.

CONCLUSION:

We developed a unique predictive scoring system in order to differentiate between patients with and without high risk for developing morbid hypothalamic obesity.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Hipofisárias / Obesidade Mórbida / Craniofaringioma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Female / Humans / Male Idioma: En Revista: Childs Nerv Syst Assunto da revista: NEUROLOGIA / PEDIATRIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Hipofisárias / Obesidade Mórbida / Craniofaringioma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Female / Humans / Male Idioma: En Revista: Childs Nerv Syst Assunto da revista: NEUROLOGIA / PEDIATRIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos